Cas:348-40-3 2-Amino-6-fluorobenzothiazole manufacturer & supplier

Chemical Name:2-Amino-6-fluorobenzothiazole

CAS.NO:348-40-3

Synonyms:6-Fluoro-1,3-benzothiazol-2-amine;2-amino-6-fluorobenzthiazole;6-Fluorobenzo[d]thiazol-2-amine;MFCD00013336;2-Amino-6-fluorobenzothiazole;2-amino-6-fluoro-1,3-benzothiazole;6-fluoro-2-amino-1,3-benzothiazole;6-fluorobenzothiazole-2-ylamine;2-amino-6-fluoro-benzothiazole;6-fluoro-benzothiazol-2-ylamine;6-fluoro-2-benzothiazolamine;2-Benzothiazolamine,6-fluoro;2-Benzothiazolamine, 6-fluoro-

Molecular Formula:C₇H₅FN₂S

Molecular Weight:168.191

HS Code:2934999090

Physical and Chemical Properties:

Melting point:183-185 °C(lit.)

Boiling point:312.0±34.0 °C at 760 mmHg

Density:1.5±0.1 g/cm3

Index of Refraction:1.726

PSA:67.15000

Exact Mass:168.015747

LogP:1.94

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like 6-Fluoro-1,3-benzothiazol-2-amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Benzothiazolamine, 6-fluoro- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-amino-6-fluoro-1,3-benzothiazole Use and application,2-Benzothiazolamine, 6-fluoro- technical grade,usp/ep/jp grade.

Related News: At present, there are more than 8,000 domestic API manufacturers, but they mainly produce bulk APIs with low technical content. 2-Amino-6-fluorobenzothiazole manufacturer For both Black and white women, younger age and ER-negative breast cancer were risk factors in the genes most strongly associated with breast cancer, including BRCA1, BRCA2 and PALB2. 2-Amino-6-fluorobenzothiazole supplier The Wuhan coronavirus has brought back memories of the 2003 outbreak of the severe acute respiratory syndrome, known as SARS, which infected more than 8,000 people and killed 774. 2-Amino-6-fluorobenzothiazole vendor In approving the first new Alzheimer’s drug in nearly 20 years, the U.S. Food and Drug Administration is taking its biggest risk yet with a strategy that allows new therapies onto the market without strong evidence that they work, regulatory and scientific experts say. 2-Amino-6-fluorobenzothiazole factory The Wuhan coronavirus has brought back memories of the 2003 outbreak of the severe acute respiratory syndrome, known as SARS, which infected more than 8,000 people and killed 774.